Stem cell therapy for ischemic heart diseases.

Yu, Hong; Lu, Kai; Zhu, Jinyun; Wang, Jian'an

Yu, Hong; Lu, Kai; Zhu, Jinyun; Wang, Jian'an.

Affiliation

Yu H; Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, 310009, P.R. China.
Lu K; Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, Zhejiang Province, 310009, P.R. China.
Zhu J; Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, 310009, P.R. China.
Wang J; Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, Zhejiang Province, 310009, P.R. China.

Br Med Bull ; 121(1): 135-154, 2017 01 01.

Article in En | MEDLINE | ID: mdl-28164211

Subject(s)

Cell- and Tissue-Based Therapy; Heart Failure/prevention & control; Myocardial Infarction/prevention & control; Myocardial Ischemia/therapy; Stem Cell Transplantation; Adipocytes; Cell-Free System; Clinical Trials as Topic; Disease Progression; Embryonic Stem Cells; Endothelial Progenitor Cells; Genetic Therapy; Heart Failure/etiology; Humans; Mesenchymal Stem Cells; Myocardial Infarction/etiology; Myocardial Ischemia/complications; Myocardial Ischemia/physiopathology; Myocytes, Cardiac; Stem Cell Transplantation/trends

Key words

angiogenesis; exosome; genetic modification; ischemic heart diseases; preconditioning; stem cells; transplantation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocardial Ischemia / Stem Cell Transplantation / Cell- and Tissue-Based Therapy / Heart Failure / Myocardial Infarction Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br Med Bull Year: 2017 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google